Find similar content

Source channel @githubtrending · Post #14679 · May 7

#typescript#chatgpt#claude#copilot#cursor#developer_tools#editor#llm#open_source#openai#visual_studio_code#vscode#vscode_extension Void is a free, open-source code editor that works like Cursor but gives you more control over your data and lets you use any AI model you want, including ones you run yourself. It’s built on top of VS Code, so you can keep your favorite settings and themes. Void offers features like AI-powered code completion, quick edits, and chat with different AI models, and you can even see and change the prompts the AI uses. This means you can code faster, work privately, and use the latest AI tools without being locked into one provider or worrying about your data being sent elsewhere[1][2][4]. https://github.com/voideditor/void

Hashtags

#typescript #chatgpt #claude #copilot #cursor #developer_tools #editor #llm #open_source #openai #visual_studio_code #vscode #vscode_extension

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment